Home › Funds › Catalio Capital Management, LP › GILD

Catalio Capital Management, LP position in GILD

GILEAD SCIENCES INC · Health Care

Catalio Capital Management, LP reported holding 269,309 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$34.0M, representing 6.39% of its reported portfolio and ranking #3 among its reported holdings. Catalio Capital Management, LP has disclosed GILD holdings in 4 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)269.31K sh
Reported value held$34.02M
Portfolio Weight6.39%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Catalio Capital Management, LP's GILD position evolved

Catalio Capital Management, LP first disclosed a stake in GILD in Q2 2025 at 226,875 shares (US$25.2M). The position peaked in Q4 2025 at 289,312 shares, worth US$35.5M. Across 4 filings, Catalio Capital Management, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 269,309 shares valued at US$34.0M — an increase of 105,404 shares quarter over quarter.. Notable position changes include a 43% trim in Q1 2026 (shares fell 10% over the following quarter), a 64% increase in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 226.88K $25.15M New
Q4 2025 289.31K $35.51M New
Q1 2026 163.91K $22.84M Reduce
Q2 2026 269.31K $34.02M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Catalio Capital Management, LP held GILD?

Catalio Capital Management, LP has disclosed GILD holdings in 4 of the last 5 reported quarters, going back to Q2 2025.

What is Catalio Capital Management, LP's current position in GILD?

As of Q2 2026, Catalio Capital Management, LP holds 269.31K shares of GILD (GILEAD SCIENCES INC), valued at $34.02M, representing 6.39% of its reported portfolio and ranking #3.

Has Catalio Capital Management, LP been buying or selling GILD?

In the latest 13F filing (Q2 2026), Catalio Capital Management, LP increased its position in GILD. The position peaked in Q4 2025 at 289.31K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.